Dolby Laboratories (DLB) Tops Q4 EPS by 29c, Beats on Revenue; Offers Guidance

Dolby Laboratories (NYSE: DLB) reported Q4 EPS of $0.99, $0.29 better than the analyst estimate of $0.70. Revenue for the quarter came in at $307 million versus the consensus estimate of $305.76 million.

GUIDANCE:

Dolby Laboratories sees FY2026 EPS of $4.19-$4.34, versus the consensus of $3.96. Dolby Laboratories sees FY2026 revenue of $1.39-1.44 billion, versus the consensus of $1.35 billion.

For earnings history and earnings-related data on Dolby Laboratories (DLB) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• AeroVironment restates quarterly financials, citing $89M goodwill error
• Trump's CDC nominee to exit UnitedHealth, divest holdings